A Medical Device Daily

Natus Medical (San Carlos, California) reported completing its previously disclosed $18 million acquisition of privately held NeuroCom International (Clackamas, Oregon), which develops computerized systems for the assessment and rehabilitation of balance and mobility disorders (Medical Device Daily, Sept. 4, 2008).

NeuroCom reported revenue of $11.3 million in the 12 months ended June 30, and had cash of about $3.6 million as of the closing.

Natus said it believes the acquisition will be immediately accretive to earnings, excluding associated one-time charges.

"This acquisition expands our neurology footprint into the growing balance and mobility assessment market," said Jim Hawkins, president/CEO of Natus. "We are very excited about the growth opportunities in this developing field and we believe NeuroCom products can become the standard of care in this emerging field."

Natus said it intends to update its revenue and earnings guidance for the fourth quarter and full year 2008 when it releases financial results for its third quarter ended Sept. 30.

Natus is a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders and newborn care.

In other dealmaking news, Quantros (Milpitas, California), a provider of safety, quality and compliance software data infrastructure solutions for the healthcare industry, reported the acquisition of Medcast Health Analytics, a provider of web-based clinical utilization and financial analytic solutions.

The company said the integration of Medcast technologies within the Quantros Platform will offer healthcare organizations a new level of safety and quality performance insight and intervention impact analyses, according to the companies.

Quantros solutions combined with Medcast's technology create a means of accessing associated clinical, financial and operational data within a single, integrated platform.

Quantros said this combination will enable real-time analysis of various intervention efforts and their corresponding impact on such measures as length of stay, charges, system inefficiencies, and readmission rates. Access to this information is critical given the P4P and "at risk" reimbursement environment in which healthcare organizations operate.